Director
President / CEO
Masahiro Morimoto Masahiro MorimotoBorn in Osaka in 1966. After graduating from the National Defense Academy in 1989, he served as an escort ship for the Japan Maritime Self-Defense Force.After retiring, he worked at Applied Materials Japan Co., Ltd., a semiconductor manufacturing equipment manufacturer, before establishing UBIC (currently FRONTEO) in 2003.He supports international lawsuit measures of global companies with big data analysis technology, and also promotes the development and practical application of the AI engine "KIBIT" that applies the research results of natural language processing and artificial intelligence. In 2007, it was listed on the Tokyo Stock Exchange Mothers (currently Tokyo Stock Exchange Growth), and in 2013 it was listed on the NASDAQ* in the United States.Currently, in addition to legal tech AI, including forensic investigations and international litigation support, which are the founding businesses, he has expanded his business fields to business intelligence, life science AI, and economic security. Leading research and development.He is a Certified Fraud Examiner (CFE), a director of the NPO Digital Forensics Research Association, and a member of the Police Policy Society. * Delisted in February 2020
Director/CTO
Hiroyoshi Toyoshiba Hiroyoshi ToyoshibaHe majored in mathematics at the Graduate School of Science and Engineering, Waseda University. While studying for his PhD in Mathematics (Mathematics, obtained his PhD in 2000), he was in charge of statistical analysis of medical data at the Medical Information Department of Kyushu University Hospital from 1999. Since 2000, he has participated in research on the carcinogenesis process through data analysis at the National Institute of Environmental Health Sciences (NIEHS) in the United States. Since 2004, he has been engaged in research on statistical analysis of toxicity data and epidemiological study design and data analysis at the National Institute for Environmental Studies. In 2006, he joined Takeda Pharmaceutical Company, Ltd., where he has served as a researcher in the bioinformatics field, head of bioinformatics at the Global Data Science Institute Japan site, and science fellow. He has also been involved in gene expression data analysis and target discovery in clinical trial data, as well as biomarker discovery in immunity and cancer. Since 2017, he has been involved in the development of life science AI at FRONTEO, where he develops AI algorithms specialized for the field of life science. Taking advantage of the feature of text vectorization, we have developed various AI products based on this artificial intelligence, such as paper search, drug discovery support, dementia diagnosis support, and fall prediction. He became CTO of Life Science AI in 2019 and an executive officer in 2021. He will be a director in 2024.
Director
Mari Yamamoto Mari YamamotoAfter joining an advertising agency, he worked at a risk management company. He launched a mental health care business and implemented business plans, product development, marketing, and sales strategies, leading the company to become the industry leader. He became a director in 2014 and achieved listing on the First Section of the Tokyo Stock Exchange in 2017. He joined FRONTEO in 2018 and became a director in 2020.
Outside director
Director Makoto Funahashi Makoto Funahashi |
Director Hirooki Kirizawa Hirouki Kirisawa |
Director Taeko Nagayama Taeko Nagayama |
Director Masao Torii Masao Torii |
Outside Audit & Supervisory Board Member
Full-time Statutory Auditor Kunihiro Sudo Kunihiro Sudo |
Statutory Auditor Takaharu Yasumoto Takaharu Yasumoto |
Statutory Auditor Kei Okubo Kei Okubo |
Executive Officer
Executive Officer
Naritomo Ikeue Naritomo IkeueAfter graduating from Chiba University Faculty of Science, joined Applied Materials Japan Co., Ltd., a manufacturer of semiconductor manufacturing equipment. He joined UBIC (now FRONTEO), which was just established in 2003.
Overseeing a wide range of sales and planning, including digital forensics business, discovery support business (support for disclosure of evidence in international lawsuits), and risk consulting business, and contributed greatly to the launch of FRONTEO's founding business.
Since 2015, as a new business launch, we have worked to expand the application fields of the artificial intelligence engine "KIBIT" developed in-house, laying the foundation for the current business intelligence field and life science field.At the same time, we acquired an e-discovery vendor in the United States (currently FRONTEO USA, Inc.) through M&A, expanding our business in the United States and greatly contributing to the acceleration of global expansion.
As Executive Officer in charge of global legal tech AI business, we propose an innovative e-discovery service that fully utilizes our unique AI, KIBIT Automator, to the labor-intensive legal tech industry, which has long relied solely on human power. and aim to expand business through the spread of AI.
Executive Officer
Hiromi Kunieda Hiromi KuniedaAfter joining a semiconductor trading company, he worked at a tax accountant's office. In 2012, he joined UBIC (now FRONTEO). Since then, he has been engaged in accounting and finance work, and has been responsible for overseeing the accounting and finance aspects of subsidiaries not only in Japan, but also in the US, Korea, and Taiwan, supporting FRONTEO's global business development.
At the same time, he played a central role in executing the post-merger integration process (PMI) at UBIC North America, Inc. (now FRONTEO USA) and working to correct and strengthen internal control issues, making a significant contribution to smooth business operations.
He will become head of the Accounting and Finance Division in 2021 and director of FRONTEO Korea and FRONTEO Taiwan in 2023.
He will be appointed as an executive officer in 2024 and will oversee the corporate departments of accounting and finance, human resources, legal affairs, general affairs, and information systems.
Overseas Subsidiary Country Manager
CEO, FRONTEO USA, Inc. / FRONTEO Taiwan, Inc.
Naritomo Ikeue Naritomo Ikeue
CEO, FRONTEO Korea, Inc.
Zheng Chang Chang Il JeongAdvisory board
Professor, Department of Systems Innovation, Graduate School of Engineering, The University of Tokyo
Yukio Osawa Yukio OsawaAfter obtaining a doctor of engineering from the Graduate School of Engineering, the University of Tokyo in 1995, he became an assistant professor at the Graduate School of Engineering, Osaka University, an assistant professor at the Graduate School of Business Sciences at Tsukuba University, a specially appointed assistant professor at the Graduate School of Information Science and Engineering, the University of Tokyo, and the system creation of the Graduate School of Engineering. After working as an associate professor in the Department of Science, he has been a professor since July 2009.He founded opportunity discovery science and data market design science at the boundary between intelligent informatics and design science, cognitive science, and held international conferences and industry-academia WS. From 7 onwards, he will lead workshops such as Market of Data to success at the IEEE Data Mining International Conference (ICDM) from the perspective of the data market. In addition to 2013 editorial books including Chance Discovery (Springer, 2003), Innovators' Marketplace (Springer 2017), Data Market (Modern Science Co., Ltd. 2017), more than 24 journal articles, about 100 international conference treatises, in both industry and academia. Many invited lectures.
In addition, former director of the Japanese Society for Artificial Intelligence (2017-18).Received the Achievement Award of the Japanese Society for Artificial Intelligence (2017).
Recent publications Technology for discovering business opportunities (Iwanami Shoten, 2004), Data analysis for discovering opportunities (Tokyo Denki University Press, 2006), Ideation technology for innovation: business opportunities opened by games (Nihon Keizai Shimbun Publishing, Inc.) 2013)” “Data Market: Innovation Game Utilizing Data (Kindai Kagaku-sha, 2017)”
Strategic Advisor
Toshiyuki Ito Toshiyuki Ito
Graduated from the Department of Mechanical Engineering, National Defense Academy, and completed the master's program (area studies) at the University of Tsukuba.Became a submarine rider in the Maritime Self-Defense Force.Captain Hayashio, Defense Attaché of the Japanese Embassy in the United States, Commander of the 2nd Submarine, Chief of the Public Relations Office of the Maritime Staff Office, Chief of the Information Division, Information Officer of the Defense Intelligence Headquarters, Chief of the Command and Communication Information Department of the Maritime Staff Office, Maritime Self-Defense Force After working as the second art school chief, the integrated staff school chief, and the Maritime Self-Defense Force Kure district general manager, he has been a professor at the Kanazawa Institute of Technology Graduate School (Toranomon Campus) since 2 (Department of Innovation Management, Graduate School of Innovation Management).
Specialty: Leadership/Followership, Risk Management, Defense/Security
Papers/Books
Dissertation: Russian Foreign Policy (Analysis from Cultural Anthropological Aspects)
・Book: “Textbook for General Staff” (Futabasha 2023)
・ Supervision: "Defense Simulation! Self-Defense Forces vs Unified Korea" (Takarajimasha 2020)
・Sankei Shimbun correct column, Jiji Press comment liner writer, Nippon Journal, Bunka Broadcasting Broadcasting “Good Morning Tera-chan” commentator, and other media appearances
Awards: Received "The Legion of Merit" from the US Defense Attaché for his work as a Defense Attaché, and "The Legion of Merit" from the US Defense Secretary for his work as Chief of the Sea
Other professional information: Serves as a permanent director of the National Federation of Defense Associations.
Professor, Research Center for Advanced Science and Technology, University of Tokyo
Katsuya Tamai Katsuya TamaiGraduated from the Faculty of Law, University of Tokyo in 1983.In April of the same year, he was an assistant at the Faculty of Law, the University of Tokyo.After that, he became a lecturer at the Faculty of Law at Gakushuin University and an assistant professor at the same time. In October 4, he was transferred to the university and became an assistant professor at the Research Center for Advanced Science and Technology (Research Center for Advanced Science and Technology), the University of Tokyo. In May 1990, he became the professor (Intellectual Property Law) at the age of 4, and continues to this day.In addition to legal research on intellectual property law, he has published numerous research papers on legislative policy, industry-academia collaboration, and technology transfer.It is a pioneer in Japan regarding trade secrets, and its research theme is the "sovereign immunity" principle in the United States. In 1995, the Institute for Advanced Science and Technology launched the "Economic Security Research Program" to study economic security policies of major countries, legislation related to advanced technology management, and risk countermeasures. 10-1997 Keio University Special Invited Professor. Registered as a lawyer in 5 (belonging to the Dai-Ichi Tokyo Bar Association). Since April 36, he has also served as a professor at the Faculty of Economics and Law, Shinshu University.
Specially Appointed Professor, Graduate School of Science, Tokyo University of Science
Masayuki Murata Masayuki MurataIn 1988, he completed his doctoral course at the Graduate School of Science, Kyoto University (Science). In 1989, he became an assistant professor at the Quantum Biology Course, Department of Biophysics, Graduate School of Science, Kyoto University. During that time, he studied abroad as a visiting researcher at the European Molecular Biology Laboratory (EMBL) in Germany and the University of California, Berkeley in the United States from 1993 to 1995. In 1996, he became an associate professor at the National Institute for Physiological Sciences, Okazaki National Research Institute. In 2003, he became a professor at the Department of Life and Environmental Sciences, Department of Multi-Disciplinary Sciences, Graduate School of Arts and Sciences, University of Tokyo. During that time, he also served as a special professor at the University of Tokyo/Nikon Corporation Social Collaboration Program "Next Generation Imaging Image Analysis Course." He also served as a special professor at the Cellular Engineering Research Center, Institute of Innovative Research, Tokyo Institute of Technology. In 2021, he retired from the University of Tokyo (Professor Emeritus, University of Tokyo). From 2021, he will be a special professor at the Institute of Innovative Research (now the Institute of Innovative Research), Tokyo Institute of Technology (now Tokyo University of Science). From 2022, he will be the director of the Multimodal Cell Analysis Collaborative Research Center, Tokyo Institute of Technology (now Tokyo University of Science). He is also a specially appointed professor at the International Research Center for Neurointelligence (IRCN), International Institute for Advanced Studies, University of Tokyo, and a visiting professor at Jichi Medical University.
Aiming to create a new life science that combines morphological information (cell biology, biophysics, etc.) and molecular information (biochemistry, molecular biology, etc.), we developed a "covariation network analysis technique (PLOM-CON method)" that stratifies cell states based on the temporal synchronization of biomolecules, mainly proteins, in cells, based on a large number of cell (stained) images. We also constructed a "semi-intact cell resealing method" that can temporarily make the cell membrane permeable, exchange cytoplasm while maintaining the morphology and three-dimensional arrangement of organelles and cytoskeleton in the cell, and analytically reconstruct various life phenomena (signal transduction, organelle dynamics, etc.) that occur in a synchronized cytoplasmic environment, and established a method to create various pathological model cells and analyze the pathological expression factors. The former is a technology that can be used for "cell design" and "cell evaluation" to create cellular states under specific conditions, and the latter is a new technology that enables "cell editing" by changing the drama type of a cell without genetic modification of the cell. By combining these two new technologies and rapidly cycling through the cycle of "cell design → editing → evaluation," we are working to create a "cell design" center that will enable network-based analysis of stratified new drug efficacy, main actions, side effects, and toxicity expression, as well as the creation of safe, new, functionally activated cells without genetic modification.